Christine D. Baker

Insider Reports History

Location
New York, NY
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine D. Baker:

Company Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Operating Officer Stock Option (Right to Buy) 275,800 $827,400 $3.00 14 Apr 2023 Direct
TYME TECHNOLOGIES, INC. Director Director Stock Option - Option to buy 0 16 Sep 2022 Direct

Insider Reports Filed by Christine D. Baker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOOK HOOKIPA Pharma Inc. 14 Apr 2023 1 $0 4 Chief Operating Officer 18 Apr 2023, 19:47
/report/000089924322031346-baker-christine-d-2022-09-16 TYME TECHNOLOGIES, INC. 16 Sep 2022 3 $0 4 Director 16 Sep 2022, 18:00
/report/000089924322029938-baker-christine-d-2022-08-24 TYME TECHNOLOGIES, INC. 24 Aug 2022 1 $0 4 Director 29 Aug 2022, 06:30
HOOK HOOKIPA Pharma Inc. 30 Jun 2022 1 $0 4 Chief Operating Officer 01 Jul 2022, 16:06
HOOK HOOKIPA Pharma Inc. 19 Apr 2022 1 $0 4 Chief Business Officer 20 Apr 2022, 16:25
/report/000089924322012206-baker-christine-d-2022-03-23 TYME TECHNOLOGIES, INC. 23 Mar 2022 2 $0 4 Director 25 Mar 2022, 08:35
/report/000089924322012205-baker-christine-d-2022-03-23 TYME TECHNOLOGIES, INC. 23 Mar 2022 0 $0 3 Director 25 Mar 2022, 08:30
HOOK HOOKIPA Pharma Inc. 01 Feb 2022 2 +$109,263 4 Chief Business Officer 01 Feb 2022, 19:50